Skip to main content

CITADEL ADVISORS LLC

Position in SLGL — Sol-Gel Technologies Ltd.

CIK 1423053 MIAMI, FL

Position in SLGL

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$2,413,701
-$528,925 QoQ
Shares Held
32,556
-12.4% QoQ
Ownership
0.994%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 24 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLGL Over Time

Shares Held

Position Value (USD)

Derivatives in SLGL

reported options exposure · as of Mar 31, 2025
CallValue
$10,452
CallShares
2,010
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. SLGL ranks #193 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLGL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,413,701 32,556
2026-03-31 $2,942,626 37,145
2025-12-31 $261,225 6,199
2025-03-31 $1,692 3,255
2025-03-31 $10,452 20,100
2024-12-31 $11,904 12,800
2024-09-30 $1,020 1,500
2024-09-30 $26,947 39,629
2024-06-30 $4,806 5,400
2024-06-30 $9,944 11,174
2024-03-31 $196 200
2024-03-31 $294 300
2024-03-31 $10,973 11,197
2023-12-31 $221 200
2023-12-31 $552 500
2023-12-31 $19,071 17,259
2023-09-30 $21,912 13,443
2023-09-30 $815 500
2023-06-30 $53,084 17,754
2023-06-30 $2,392 800
2023-06-30 $14,950 5,000
2022-03-31 $94,464 12,800
2021-06-30 $123,800 10,000